Clearance Summary
OCL CONTOUR received FDA 510(k) clearance under submission number K945035, sponsored by M-Pact Worldwide, LLC. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 1994-11-15.
- Submission: K945035
- Applicant / Sponsor: M-Pact Worldwide, LLC
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1120
- Decision date: 1994-11-15
Classification & Regulation
This clearance is catalogued under FDA product code DXQ and 21 CFR 870.1120, within the Cardiovascular review panel as a Class II device.